biote Corp. (BTMD)

4.0400

+0.0400

+(1.00%)

As of 3:33:34 PM EDT. Market Open.

biote Corp. Just Recorded A 469% EPS Beat: Here's What Analysts Are Forecasting Next

biote Corp. ( NASDAQ:BTMD ) investors will be delighted, with the company turning in some strong numbers with its...

Simply Wall St. 2 days ago

BTMD
+1.00%
Biote Corp (BTMD) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Restructuring ...

Biote Corp (BTMD) reports a strong start to 2025 with increased revenue and strategic initiatives, despite facing procedural revenue challenges and restructuring costs.

GuruFocus.com 4 days ago

BTMD
+1.00%
Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates

biote Corp. (BTMD) delivered earnings and revenue surprises of 33.33% and 3.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 days ago

BTMD
+1.00%
Biote Reports First Quarter 2025 Financial Results

IRVING, Texas, May 07, 2025--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2025.

Business Wire 4 days ago

BTMD
+1.00%
Biote Schedules First Quarter 2025 Financial Results Release and Conference Call

IRVING, Texas, April 23, 2025--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on Wednesday, May 7, 2025, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.

Business Wire 18 days ago

BTMD
+1.00%
biote Corp. (BTMD): Insider Were Buying In Q1 2025

We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where biote Corp. (NASDAQ:BTMD) stands against other micro-cap stocks insiders were buying in Q1 2025. The White House announced Tuesday that Trump’s tariffs would take effect immediately after being […]

Insider Monkey last month

BTMD
+1.00%

COMP
Marc Beer Buys Handful Of Shares In biote

Investors who take an interest in biote Corp. ( NASDAQ:BTMD ) should definitely note that the Executive Chairman, Marc...

Simply Wall St. last month

BTMD
+1.00%
Biote Announces Purchase of Shares by Directors and CEO

IRVING, Texas, March 18, 2025--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company") a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of Biote’s common stock, acquiring an aggregate of approximately 260,000 shares.

Business Wire last month

BTMD
+1.00%
biote Full Year 2024 Earnings: EPS Misses Expectations

biote ( NASDAQ:BTMD ) Full Year 2024 Results Key Financial Results Revenue: US$197.2m (up 6.4% from FY 2023). Net...

Simply Wall St. last month

BTMD
+1.00%
Q4 2024 Biote Corp Earnings Call

Q4 2024 Biote Corp Earnings Call

Thomson Reuters StreetEvents last month

BTMD
+1.00%
Biote Corp (BTMD) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Initiatives ...

Biote Corp (BTMD) reports a 9% revenue increase and strategic advancements, despite facing procedural growth challenges and increased expenses.

GuruFocus.com last month

BTMD
+1.00%
Biote Corp. (BTMD) Q4 Earnings Beat Estimates

biote Corp. (BTMD) delivered earnings and revenue surprises of 11.11% and 2.85%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

BTMD
+1.00%
Biote Reports Fourth Quarter and Full Year 2024 Financial Results

IRVING, Texas, March 12, 2025--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the fourth quarter and full year ended December 31, 2024.

Business Wire last month

BTMD
+1.00%
Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

IRVING, Texas, February 26, 2025--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide fourth quarter and full year financial results on Wednesday, March 12, 2025, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.

Business Wire 2 months ago

BTMD
+1.00%
Biote Announces CEO Retirement and Succession Plan

IRVING, Texas, January 30, 2025--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Terry Weber is retiring as Chief Executive Officer and stepping down from the Company’s Board of Directors, effective as of February 1, 2025. She will be transitioning to Strategic Advisor to the Company’s Board of Directors. Concurrently, Mr. Bret Chr

Business Wire 3 months ago

BTMD
+1.00%
Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?

Here is how biote Corp. (BTMD) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks 4 months ago

DOCS

BTMD
+1.00%
Should Value Investors Buy biote Corp. (BTMD) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 4 months ago

OSUR

BTMD
+1.00%
Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect?

The mean of analysts' price targets for biote Corp. (BTMD) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks 5 months ago

BTMD
+1.00%
Are Investors Undervaluing biote Corp. (BTMD) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 5 months ago

BTMD
+1.00%
biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for biote Corp. (BTMD), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks 5 months ago

BTMD
+1.00%

Performance Overview

Return	BTMD	S&P 500 (^GSPC)
YTD	-34.63%	-0.84%
1-Year	-33.99%	+11.67%
3-Year	-59.47%	+48.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

TARIFFS LATEST

biote Corp. (BTMD)

biote Corp. Just Recorded A 469% EPS Beat: Here's What Analysts Are Forecasting Next

Biote Corp (BTMD) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Restructuring ...

Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates

Biote Reports First Quarter 2025 Financial Results

Biote Schedules First Quarter 2025 Financial Results Release and Conference Call

biote Corp. (BTMD): Insider Were Buying In Q1 2025

Marc Beer Buys Handful Of Shares In biote

Biote Announces Purchase of Shares by Directors and CEO

biote Full Year 2024 Earnings: EPS Misses Expectations

Q4 2024 Biote Corp Earnings Call

Biote Corp (BTMD) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Initiatives ...

Biote Corp. (BTMD) Q4 Earnings Beat Estimates

Biote Reports Fourth Quarter and Full Year 2024 Financial Results

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

Biote Announces CEO Retirement and Succession Plan

Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?

Should Value Investors Buy biote Corp. (BTMD) Stock?

Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect?

Are Investors Undervaluing biote Corp. (BTMD) Right Now?

biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Performance Overview